Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

roche

Roche growth stalls after Avastin setback

April 14, 2011 Research and Development, Sales and Marketing Roche

Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …
News
GP prescribing

GPs asked to squeeze drugs bill

April 14, 2011 Sales and Marketing AZ, GPs, NHS, NICE, prescribing

GPs are being asked not to prescribe NICE-approved drugs in order to cut costs.In the last year more than half …
News
Lonza, Slough

Lonza expands UK facility, bio business reports growth

April 13, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, Lonza, Slough, manufacturing

Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …
News

FDA committee votes in Afinitor’s favour

April 13, 2011 Research and Development, Sales and Marketing

The FDA advisory committee has unanimously backed Novartis’ Afinitor for neuroendocrine tumours of pancreatic origin.  The recommendation comes from the …
News

Free Pharmacovigilance Training Webinar

April 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 Wainwright Associates are offering you the opportunity to attend a FREE thirty minute webinar on “The roles and responsibilities of …
News
Press release
hamedprasadweb

Indian firm Dr Reddy’s opens UK site

April 12, 2011 Sales and Marketing Cambridge, Chirotech, Dr Reddy's, India, generics

Indian firm Dr Reddy’s has confirmed the UK is still attractive for investment as it opens its new pharma services …
News
Mumbai

Merck teams up with Sun on emerging markets generics

April 12, 2011 Sales and Marketing India, Merck, Sun Pharma, emerging markets

Merck Inc has created a joint venture with Indian firm Sun Pharmaceutical Industries to develop, manufacture and market branded generics …
News

Bayer drug enters phase III for diabetic macular oedema

April 11, 2011 Sales and Marketing Bayer, Lucentis, ophthalmology

Bayer and partner Regeneron have begun late stage trials for their VEGF Trap Eye candidate for diabetic macular oedema. The …
News

GSK and Valeant’s epilepsy treatment approved

April 8, 2011 Sales and Marketing GSK, Trobalt, Valeant, epilepsy

The European Commission has granted marketing authorisation for Trobalt, the new epilepsy drug from GSK and Valeant. Trobalt (retigabine) has …
News

Eisai sets up in Brazil

April 8, 2011 Sales and Marketing Brazil, Eisai

Japanese pharma company Eisai has set up its first operations in Latin America, establishing a sales subsidiary in Brazil. Based …
News

AZ gets green light for thyroid cancer drug

April 7, 2011 Sales and Marketing AstraZeneca, zactima

AstraZeneca’s Zactima has become the first treatment to be approved for a rare form of thyroid cancer. The orphan drug …
News

Working Life: Merck Serono’s Wolfgang Wein

April 6, 2011 Research and Development, Sales and Marketing Working Life

Head of oncology at Merck Serono Wolfgang Wein explains how his field is changing, the best thing about his role …
News

John Gargiulo to lead Daiichi Sankyo in the US

April 6, 2011 Sales and Marketing appointment, sales and marketing

Daiichi Sankyo has appointed John Gargiulo as its president and chief executive in the US. He succeeds Joseph Pieroni who …
Appointment

Evil big pharma: myth or material?

April 6, 2011 Research and Development, Sales and Marketing Les Rose, industry reputation

In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …
Feature

Merck acquires eyecare specialist Inspire

April 6, 2011 Research and Development, Sales and Marketing Inspire, Merck, eye care

Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026